Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction
Sponsored by Chinese PLA General Hospital
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Started 6 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- 1.18~75 years old
- 2.The tumor center located at the esophagogastric junction(EGJ) line from 1cm above to 2cm below(SiewertⅡ) .
- 3.Histological diagnosis of adenocarcinoma -
- 5.Informed consent of patients
Exclusion Criteria
- 1.Patients with distant metastasis (M1) or invasion of surrounding organs
- 2.History of esophagectomy and gastrectomy (including endoscopic mucosal resection/endoscopic submucosal dissection for gastric cancer and esophageal cancer)
- 3.History of other malignant tumors within 5 years
- 4.The researcher believes that the patient is not suitable to participate in the clinical trial
- 5.Patients who persist in withdrawing from clinical trials